Who invested in Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals's investors include RA Capital Management, New Enterprise Associates, Wellington Management, TPG and Vivo Capital.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$92Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by FinSMEsSEC filing: $6.0M sold, first sale Dec 2016
From Satsuma Pharmaceuticals's own website and the SEC filings it signed: 7 on the team.
On the board, as filediHeath LukatchMichael RiebeRajeev Shah
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Satsuma Pharmaceuticals's investors include RA Capital Management, New Enterprise Associates, Wellington Management, TPG and Vivo Capital.
Satsuma Pharmaceuticals has raised $92M across 2 rounds since 2017.
Satsuma Pharmaceuticals's most recent round was an Undisclosed round of $80M in Mar 2021.
Its most recent round, $80M in Mar 2021, is also its largest on record.
Satsuma Pharmaceuticals's first round on record, in Jan 2017, was backed by RA Capital Management and TPG.
Satsuma Pharmaceuticals's latest named round is an Undisclosed round, in Mar 2021.
Satsuma Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.